Skip to Content
Merck
  • RGS4 controls secretion of von Willebrand factor to the subendothelial matrix.

RGS4 controls secretion of von Willebrand factor to the subendothelial matrix.

Journal of cell science (2020-06-25)
Francesca Patella, Daniel F Cutler
ABSTRACT

The haemostatic protein von Willebrand factor (VWF) exists in plasma and subendothelial pools. The plasma pools are secreted from endothelial storage granules, Weibel-Palade bodies (WPBs), by basal secretion with a contribution from agonist-stimulated secretion, and the subendothelial pool is secreted into the subendothelial matrix by a constitutive pathway not involving WPBs. We set out to determine whether the constitutive release of subendothelial VWF is actually regulated and, if so, what functional consequences this might have. Constitutive VWF secretion can be increased by a range of factors, including changes in VWF expression, levels of TNF and other environmental cues. An RNA-seq analysis revealed that expression of regulator of G protein signalling 4 (RGS4) was reduced in endothelial cells (HUVECs) grown under these conditions. siRNA RGS4 treatment of HUVECs increased constitutive basolateral secretion of VWF, probably by affecting the anterograde secretory pathway. In a simple model of endothelial damage, we show that RGS4-silenced cells increased platelet recruitment onto the subendothelial matrix under flow. These results show that changes in RGS4 expression alter levels of subendothelial VWF, affecting platelet recruitment. This introduces a novel control over VWF function.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Milli-Mark® Anti-CD41-FITC Antibody, clone 5B12, clone 5B12, Milli-Mark®, from mouse
Sigma-Aldrich
Triton X-100, laboratory grade